Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 54


Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management.

Ventriglio A, Gentile A, Stella E, Bellomo A.

Front Neurosci. 2015 Sep 3;9:297. doi: 10.3389/fnins.2015.00297. eCollection 2015. Review.


Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.

Vigod SN, Gomes T, Wilton AS, Taylor VH, Ray JG.

BMJ. 2015 May 13;350:h2298. doi: 10.1136/bmj.h2298.


Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics.

Schneiderhan ME, Shuster SM, Davey CS.

Prim Care Companion CNS Disord. 2014 Oct 30;16(5). doi: 10.4088/PCC.14m01669. eCollection 2014.


Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES).

Rethorst CD, Bernstein I, Trivedi MH.

J Clin Psychiatry. 2014 Dec;75(12):e1428-32. doi: 10.4088/JCP.14m09009.


Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.

Steiner J, Martins-de-Souza D, Schiltz K, Sarnyai Z, Westphal S, Isermann B, Dobrowolny H, Turck CW, Bogerts B, Bernstein HG, Horvath TL, Schild L, Keilhoff G.

Front Cell Neurosci. 2014 Nov 18;8:384. doi: 10.3389/fncel.2014.00384. eCollection 2014.


Potential molecular and cellular mechanism of psychotropic drugs.

Seo MS, Scarr E, Lai CY, Dean B.

Clin Psychopharmacol Neurosci. 2014 Aug;12(2):94-110. doi: 10.9758/cpn.2014.12.2.94. Epub 2014 Aug 12. Review.


Schizophrenia: current concepts and approaches to patient care.

Buckley PF, Foster A.

Am Health Drug Benefits. 2008 May;1(4):13-22.


Development and Reliability Testing of a Health Action Process Approach Inventory for Physical Activity Participation among Individuals with Schizophrenia.

Arbour-Nicitopoulos KP, Duncan M, Remington G, Cairney J, Faulkner GE.

Front Psychiatry. 2014 Jun 10;5:68. doi: 10.3389/fpsyt.2014.00068. eCollection 2014.


Almost all antipsychotics result in weight gain: a meta-analysis.

Bak M, Fransen A, Janssen J, van Os J, Drukker M.

PLoS One. 2014 Apr 24;9(4):e94112. doi: 10.1371/journal.pone.0094112. eCollection 2014.


Unmet needs in the management of schizophrenia.

Torres-González F, Ibanez-Casas I, Saldivia S, Ballester D, Grandón P, Moreno-Küstner B, Xavier M, Gómez-Beneyto M.

Neuropsychiatr Dis Treat. 2014 Jan 16;10:97-110. doi: 10.2147/NDT.S41063. eCollection 2014. Review.


Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender.

Foley DL, Mackinnon A, Watts GF, Shaw JE, Magliano DJ, Castle DJ, McGrath JJ, Waterreus A, Morgan VA, Galletly CA.

PLoS One. 2013 Dec 18;8(12):e82606. doi: 10.1371/journal.pone.0082606. eCollection 2013.


The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients.

Lizer MH, Parnapy Jawaid SA, Marsh W, Mogili L.

Pharm Pract (Granada). 2011 Jul;9(3):122-7. Epub 2011 Sep 14.


STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications.

Yarborough BJ, Leo MC, Stumbo S, Perrin NA, Green CA.

BMC Psychiatry. 2013 Sep 28;13:238. doi: 10.1186/1471-244X-13-238.


Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness.

Lang DJ, Barr AM, Procyshyn RM.

Curr Cardiovasc Risk Rep. 2013 Aug;7(4):283-287.


Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.

Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg A, Dow WH, Hui R, Frank R, Newhouse JP, Hsu J.

Med Care. 2013 Jul;51(7):614-21. doi: 10.1097/MLR.0b013e31829019c5.


Adult medication-free schizophrenic patients exhibit long-chain omega-3 Fatty Acid deficiency: implications for cardiovascular disease risk.

McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pandey GN.

Cardiovasc Psychiatry Neurol. 2013;2013:796462. doi: 10.1155/2013/796462. Epub 2013 Feb 27.


Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells.

Contreras-Shannon V, Heart DL, Paredes RM, Navaira E, Catano G, Maffi SK, Walss-Bass C.

PLoS One. 2013;8(3):e59012. doi: 10.1371/journal.pone.0059012. Epub 2013 Mar 20.


Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review.

Robillard R, Rogers NL, Whitwell BG, Lambert T.

Clin Psychopharmacol Neurosci. 2012 Apr;10(1):1-12. doi: 10.9758/cpn.2012.10.1.1. Epub 2012 Apr 30.


Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.

Johnsen E, Kroken RA.

Ther Adv Chronic Dis. 2012 Nov;3(6):287-300. doi: 10.1177/2040622312462275.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk